Yifeng Pharmacy Chain Co., Ltd. (SHA:603939)
China · Delayed Price · Currency is CNY 20.70
+0.59 (2.93%)
Jul 13, 2026, 3:00 PM CST
Yifeng Pharmacy Chain Stock Forecast
Stock Price Forecast
According to 15 analysts polled by S&P Global, Yifeng Pharmacy Chain stock has a consensus rating of "Buy" and an average price target of ¥33.22. The average 1-year stock price forecast is 60.48% higher than the current stock price, while the lowest is ¥21.00 (+1.45%) and the highest is ¥43.28 (+109.08%).
Price Target: ¥33.22 (+60.48%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Yifeng Pharmacy Chain stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 8 | 8 | 8 | 8 | 8 |
| Buy | 4 | 4 | 4 | 4 | 5 | 5 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 14 | 14 | 14 | 15 | 15 |
Financial Forecast
Revenue This Year
26.47B
from 24.43B
Increased by 8.35%
Revenue Next Year
29.01B
from 26.47B
Increased by 9.57%
EPS This Year
1.60
from 1.33
Increased by 20.30%
EPS Next Year
1.90
from 1.60
Increased by 18.91%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 27.3B | ||
| Avg | 26.5B | ||
| Low | 25.5B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 11.6% | ||
| Avg | 8.4% | ||
| Low | 4.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.63 | ||
| Avg | 1.60 | ||
| Low | 1.57 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 22.6% | ||
| Avg | 20.3% | ||
| Low | 18.0% |